Creating a defect in tRNA molecules could weaken bacteria’s two-pronged defense and help make faster-acting antibiotics
Antibiotic resistance is a major health threat, with about two million people in the U.S. getting an antibiotic-resistant infection per year, according to the Centers for Disease Control and Prevention (CDC). Gram negative bacteria, including types like E.coli and Salmonella, are often more difficult to kill because of their two-pronged defenses – they have two membranes rather than one, and also have numerous toxin pumps embedded in the membranes to expel any antibiotic that may have made it through. Now Jefferson researchers have uncovered how to target both of these defenses with one hit, which could help make antibiotics more effective.
“We showed that interfering with a transfer RNA (tRNA) molecule, in a way that is unique to bacteria, cripples the bacterial cell’s ability to make membrane proteins required for the drug barrier and efflux activity,” says senior author Ya-Ming Hou, PhD, Professor of Biochemistry at the Sidney Kimmel Medical College at Jefferson (Philadelphia University + Thomas Jefferson University). The work was published in the journal Cell Systems.
tRNA molecules are not a typical antibiotic target. These molecules are part of the protein-building machinery that is essential for the daily function of cells in every living being. However, Dr. Hou’s team examined a kind of chemical “decoration” process in bacterial tRNAs that is absent from human cells. This difference between bacteria and humans makes this process a better drug target, since it’s less likely affect human cells.
tRNAs are decorated with chemical groups that are added on after tRNAs are synthesized in a cell. Dr. Hou’s group examined one such decoration, the addition of a methyl group to one particular location on the spine of several tRNAs. In earlier work, Dr. Hou’s lab showed that when these tRNAs were deficient in this one methylation, they were more likely to create errors in protein building. But not just any protein, the deficient tRNAs were particularly prone to mistakes at building proteins that sit within cell membrane.
This result made Dr. Hou think that perhaps a defect in the tRNA methylation might affect not only the bacteria’s toxin-pump, but a host of other types of proteins that help keep the membrane stable and cohesive.
In this paper, together with first author postdoctoral fellow Isao Masuda and others, Dr. Hou tested whether these defective tRNAs could make bacteria more susceptible to antibiotics, by creating bacteria that are genetically deficient in making the methyl-group decoration.
Through an elegant series of experiments, Dr. Hou’s team showed that these bacteria had membranes that were less cohesive and more permeable than normal. The bacteria with defective tRNAs were less effective at pumping out chemicals relative to the normal bacteria, suggesting that their toxin pumps were affected. Finally, the team showed that when the bacteria with defective tRNAs were exposed to various antibiotics, they died faster and were also less capable of developing drug resistance.
“Speed of killing is important in antibiotics,” says Dr. Hou. “The longer it takes for bacteria to die from antibiotics, the more likely they are to develop resistance.”
While pharmaceutical companies such as AstraZeneca and GSK have discovered compounds that can inhibit the enzyme from making the critical methylation on tRNAs, progress has stalled. The primary reason is that the inhibitors are unable to permeate through the bacterial membrane structure, which resonates with the major challenge confronting the entire field of antibiotic discovery.
Dr. Hou acknowledges the challenge. “First, we need to formulate the inhibitors in such a way as to be able to enter the cell more effectively,” says Dr. Hou. “Then, combining these inhibitors with traditional antibiotics to kill bacteria faster and reduce the likelihood of antibiotic resistance.”
At the moment, there are no drugs that can effectively attack this pathway. Dr. Hou’s lab is currently working on developing better inhibitors.
Learn more: Breaking Open the Gates of Antibiotic Resistance
The Latest on: Antibiotic resistance
[google_news title=”” keyword=”antibiotic resistance” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antibiotic resistance
- A mother’s loss launches a global effort to fight antibiotic resistanceon May 11, 2024 at 6:00 pm
Diary Of A Dying Girl” excerpts Mallory Smith's own writings, which chronicle her 13-year battle against an antibiotic-resistant lung infection.
- Tackling the hidden pandemic of antibiotic-resistant superbugson May 11, 2024 at 10:24 am
These superbugs then transfer some drug-defeating genes to other bacteria causing a pandemic of superbugs. It’s a vicious cycle. But water is not our only worry. Recent reports of the use of ...
- Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infectionson May 9, 2024 at 12:35 pm
Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved stem cell treatments in Mexico, according ...
- A global effort to fight antibiotic resistanceon May 9, 2024 at 8:52 am
In November 2017, days after her daughter Mallory Smith died from a drug-resistant infection at the age of 25, Diane Shader Smith typed a password into Mallory’s laptop. Her daughter gave it to her ...
- Changes in pig farming in the 20th century spread antibiotic-resistant Salmonella around the world, finds studyon May 9, 2024 at 7:44 am
Historical changes in pig farming led to the global spread of Salmonella, resistant to antibiotics—a new international study led by researchers at the University of Warwick suggests.
- Antimicrobial resistance: UK’s five year plan aims to reduce antibiotic use by 5% by 2029on May 9, 2024 at 5:32 am
The government has committed to drive down antibiotic use in the UK, improve surveillance for drug resistant infections before they emerge, and incentivise research into new drugs and vaccines. Its ...
- A New Oral Antibiotic Is Available to Treat UTIson May 8, 2024 at 9:32 am
The FDA recently approved Pivya for uncomplicated UTIs. Pivya is an oral tablet that clears bacterial infections in the female bladder.
- Study recommends scaling down antibiotic prescriptions to curb antibiotic resistanceon May 7, 2024 at 7:00 am
A study on two years of antibiotic prescribing at Cork and Kerry Southdoc found that children under six accounted for 21% of all antibiotics prescribed ...
- A mother’s loss launches a global effort to fight antibiotic resistanceon May 6, 2024 at 4:59 pm
Mallory Smith, July 20, 2015 The transplant was successful, but Burkholderia cepacia — an antibiotic-resistant bacterial strain that first colonized her system when she was 12 — took hold.
- Study reveals high levels of antibiotic resistance in meat sold for consumptionon April 28, 2024 at 10:28 pm
New research presented at the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found substantial levels of resistance to critically important antibiotics in meat sold for ...
via Bing News